Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Real-World Evidence About Potential Psychosocial Harms of Lung Cancer Screening

Real-World Evidence About Potential Psychosocial Harms of Lung Cancer Screening Letters Author Affiliations: Center for Medicine and the Media, Dartmouth Institute clude notifying the patient of the finding of a nodule in a con- for Health Policy and Clinical Practice, Lebanon, New Hampshire (Schwartz, versation rather than by letter; using plain, understandable lan- Woloshin). guage that is not dismissive; explaining what the nodule looks Corresponding Author: Lisa M. Schwartz, MD, MS, Center for Medicine and the like and what it may be; providing an estimate of the likeli- Media, Dartmouth Institute for Health Policy and Clinical Practice, Geisel School hood that the nodule is cancer; explaining the plan for workup, of Medicine at Dartmouth, 35 Centerra Pkwy, Lebanon, NH 03756 (lisa.schwartz@dartmouth.edu). including expected duration of surveillance, a rationale for why Conflict of Interest Disclosures: Drs Schwartz and Woloshin report that they or why not a biopsy may be needed, and acknowledgment of are cofounders and shareholders of Informulary Inc, a provider of data about the potential harms of evaluation; and allowing time to ad- the benefits, harms, and uncertainties of prescription drugs. They prepared the dress patients’ questions and concerns. These strategies may drug facts box for Belviq, which is posted online by Consumer Reports help mitigate the distress http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Internal Medicine American Medical Association

Real-World Evidence About Potential Psychosocial Harms of Lung Cancer Screening

Loading next page...
 
/lp/american-medical-association/real-world-evidence-about-potential-psychosocial-harms-of-lung-cancer-8omw9xttxq

References (9)

Publisher
American Medical Association
Copyright
Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6106
eISSN
2168-6114
DOI
10.1001/jamainternmed.2014.1643
pmid
25090181
Publisher site
See Article on Publisher Site

Abstract

Letters Author Affiliations: Center for Medicine and the Media, Dartmouth Institute clude notifying the patient of the finding of a nodule in a con- for Health Policy and Clinical Practice, Lebanon, New Hampshire (Schwartz, versation rather than by letter; using plain, understandable lan- Woloshin). guage that is not dismissive; explaining what the nodule looks Corresponding Author: Lisa M. Schwartz, MD, MS, Center for Medicine and the like and what it may be; providing an estimate of the likeli- Media, Dartmouth Institute for Health Policy and Clinical Practice, Geisel School hood that the nodule is cancer; explaining the plan for workup, of Medicine at Dartmouth, 35 Centerra Pkwy, Lebanon, NH 03756 (lisa.schwartz@dartmouth.edu). including expected duration of surveillance, a rationale for why Conflict of Interest Disclosures: Drs Schwartz and Woloshin report that they or why not a biopsy may be needed, and acknowledgment of are cofounders and shareholders of Informulary Inc, a provider of data about the potential harms of evaluation; and allowing time to ad- the benefits, harms, and uncertainties of prescription drugs. They prepared the dress patients’ questions and concerns. These strategies may drug facts box for Belviq, which is posted online by Consumer Reports help mitigate the distress

Journal

JAMA Internal MedicineAmerican Medical Association

Published: Aug 1, 2014

There are no references for this article.